Simplifying study delivery while maximizing data output.
Assessing the Impact of the Approved FDA Guidance on Human Mass Balance Studies: How ADME programs will proceed in 2024 and beyond
Read NowOur experts
Iain Shaw is Senior Director of 14C Enabled Drug Development at Quotient Sciences. Iain has over 30 years of experience in the pharmaceutical industry, including more than 20 years of drug development experience and extensive experience with 14C human ADME studies.
Our capabilities
Our team of experts have extensive chemical and radiochemical knowledge and experience of isotopically labeling hundreds of molecular entities.